ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

CEL Celadon Pharmaceuticals Plc

61.00
1.50 (2.52%)
22 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Celadon Pharmaceuticals Plc LSE:CEL London Ordinary Share GB00BDQYGP38 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.50 2.52% 61.00 57.00 65.00 61.00 59.50 59.50 12,246 14:00:11
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Investment Advice 149k -7.14M -0.1082 -5.64 39.26M

First Project of 42 MW completed (1041K)

11/07/2011 7:00am

UK Regulatory


Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Celadon Pharmaceuticals Charts.

TIDMCEL

RNS Number : 1041K

Caparo Energy Ltd

11 July 2011

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN

 
 Press Release   11 July 2011 
 

Caparo Energy Limited

("Caparo Energy" or the "Company")

First Project of 42 MW completed

The board of directors of Caparo Energy (the "Board") is pleased to announce that the Company's first project, totalling 42 MW and comprising 20 Suzlon S-88 2.1 MW wind turbine generators ("WTG"), has been connected to the grid and commissioned.

The project is currently considered by the Board to be one of the best sites available in Rajasthan and has an overall potential for over 400 MW.

As stated in the company's update on 20(th) June, the Company has entered into a 20 year Power Purchase Agreement ("PPA") with the Rajasthan State Electricity Board for the sale of power generated by the 20 WTGs at a rate of Rs. 4.22 per kWh. The project will also receive an additional incentive of 4% over and above the energy tariff, resulting in a net tariff of Rs. 4.39 per kWh. Furthermore, the project is eligible for approval under the Generation Base Incentive Scheme to earn an additional Rs. 0.50 per kWh. The Board also expects the Company to receive revenues through CER credits.

The Company also expects that its second project in Mahidad, Gujarat, comprising 12 Suzlon S-88 2.1 MW WTGs, totalling 25.2 MW will be fully completed by mid-August 2011.

Further information on the Company can be found at www.caparoenergy.com.

- Ends -

For further information please contact:

 
 Caparo Energy Limited 
 Ravi Kailas, Chief Executive Officer             +91 40 4396 0000 
 
 Strand Hanson Limited 
 Angela Peace / Paul Cocker / James Harris    +44 (0) 20 7409 3494 
 
 Mirabaud Securities LLP 
 Peter Krens / Rory Scott                     +44 (0) 20 7878 3360 
 
 Pelham Bell Pottinger 
 Charles Vivian / Philippe Polman             +44 (0) 20 7861 3232 
 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCEAFXEFDNFEAF

1 Year Celadon Pharmaceuticals Chart

1 Year Celadon Pharmaceuticals Chart

1 Month Celadon Pharmaceuticals Chart

1 Month Celadon Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock